Virpax Pharmaceuticals, Inc. - Common Stock (NQ:VRPX)

0.6695 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virpax Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 08, 2021

Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's...

Via Benzinga

Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm ↗

December 08, 2021

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) reported results following toxicology and pharmacokinetic study of Epoladerm to manage pain associated with...

Via Benzinga

Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™

December 08, 2021

From Virpax Pharmaceuticals, Inc.

Via Business Wire

4 Penny Stocks Insiders Are Buying ↗

November 23, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

November 15, 2021

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

November 10, 2021

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Signs Agreement with Sinclair Research to Initiate Investigational New Drug (IND)-Enabling Studies for AnQlar™

October 06, 2021

From Virpax Pharmaceuticals Inc.

Via Business Wire

Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021

October 01, 2021

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children

September 20, 2021

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock

September 16, 2021

From Virpax Pharmaceuticals Inc.

Via Business Wire

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

Why Virpax Pharmaceuticals' Stock Is Trading Lower Today ↗

September 14, 2021

Virpax Pharmaceuticals (NASDAQ:VRPX) shares are trading lower after the company priced a 6.67 million share common stock offering at $6 per share. Virpax Pharmaceuticals...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb ↗

September 14, 2021

Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide ↗

September 14, 2021

Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August ↗

September 14, 2021

Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....

Via Benzinga

Topics Stocks

Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock

September 14, 2021

From Virpax Pharmaceuticals Inc.

Via Business Wire

45 Stocks Moving In Monday's Mid-Day Session ↗

September 13, 2021

Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

September 13, 2021

Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in...

Via Benzinga

60 Biggest Movers From Friday ↗

September 13, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...

Via Benzinga

Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021

September 02, 2021

From Virpax Pharmaceuticals

Via Business Wire

Why Virpax Pharmaceuticals Stock Is Trading Higher Today ↗

August 26, 2021

Virpax Pharmaceuticals (NASDAQ: VRPX) is trading higher after the company announced it entered into a commercial manufacturing and supply agreement with Seqens. The agreement with...

Via Benzinga

45 Stocks Moving In Thursday's Mid-Day Session ↗

August 26, 2021

Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,...

Via Benzinga

Virpax Announces MMS019 Manufacturing and Supply Agreement

August 26, 2021

From Virpax® Pharmaceuticals, Inc.

Via Business Wire

54 Biggest Movers From Yesterday ↗

August 26, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

Via Benzinga

36 Stocks Moving In Wednesday's Mid-Day Session ↗

August 25, 2021

Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...

Via Benzinga

The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More ↗

August 22, 2021

Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.